{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:39:08Z","timestamp":1786430348786,"version":"build-2736575974"},"reference-count":121,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/14760584.2022.2003708","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T08:13:55Z","timestamp":1636359235000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["4CMenB vaccine and its role in preventing transmission and inducing herd immunity"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6490-7707","authenticated-orcid":false,"given":"Mark","family":"McMillan","sequence":"first","affiliation":[{"name":"Women\u2019s and Children\u2019s Health Network","place":["Adelaide, Australia"]},{"name":"the University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-5166","authenticated-orcid":false,"given":"Helen S","family":"Marshall","sequence":"additional","affiliation":[{"name":"Women\u2019s and Children\u2019s Health Network","place":["Adelaide, Australia"]},{"name":"the University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[{"name":"University of Western Australia"},{"name":"Telethon Kid\u2019s Institute","place":["Perth, Western Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70251-6"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61016-2"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.04.061"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa610"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(83)92756-1"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00356-7"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/inf.1977.9.issue-2.09"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix993"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.03.007"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.01340"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.05.079"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8111675"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00333-9"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-28119-3_3"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800067492"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020988"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-0581"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/520303"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70180-1"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1636"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-018-0213-2"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-28119-3_1"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.45529-0"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1086\/648963"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1458175"},{"key":"e_1_3_5_29_1","unstructured":"Meningococcal disease: environmental Health Indicators New Zealand; 2020 [cited 2021 Jan 20]. Available from: https:\/\/www.ehinz.ac.nz\/indicators\/indoor-environment\/meningococcal-disease\/#downloads"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1258308"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1586\/erv.09.48"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7385.365"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08679-8"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30301-8"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv211"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2011.585965"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.24129"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802302-0.00002-9"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/527401"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61612-8"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.11.076"},{"key":"e_1_3_5_42_1","unstructured":"Department of Health and Public Health England. JCVI position statement on use of Bexsero\u00ae meningococcal B vaccine in the UK: Department of Health and Social Care and Public Health England; 2014 [cited 2021 March Feb]. Available from: https:\/\/www.gov.uk\/government\/publications\/meningococcal-b-vaccine-jcvi-position-statement"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2020.09.004"},{"key":"e_1_3_5_44_1","unstructured":"Meningococcal B Immunisation Program: SA Health Government of South Australia; 2020 [cited 2020 27 Apr 2020 Apr 27]. Available from: https:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/public+content\/sa+health+internet\/conditions\/immunisation\/immunisation+programs\/meningococcal+b+immunisation+program"},{"key":"e_1_3_5_45_1","unstructured":"Freitas G Marques JG and Santos SA Programa Nacional de Vacina\u00e7\u00e3o 2020. In: Sa\u00fade M-G editor Lisboa: DGS: Minist\u00e9rio da Sa\u00fade. Dire\u00e7\u00e3o-Geral da Sa\u00fade; 2020."},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.06.021"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50481"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/126.5.514"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000048"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109383"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90340-9"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3525"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00635-16"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.16.1520"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.05.006"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.7.3775-3781.2003"},{"key":"e_1_3_5_57_1","unstructured":"Sierra GV Campa HC and Varcacel NM et al. Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 1991 Dec;14(2):195\u2013207; NIPH Ann."},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93086-3"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1438028"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91961-S"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70027-5"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1381810"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.120"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn228"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.06.080"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268807009211"},{"key":"e_1_3_5_67_1","first-page":"895","volume-title":"Pathobiology and Immunobiology of Neisseriaceae","author":"Rosenqvist E","year":"1994","unstructured":"Rosenqvist E, Bjune G, and Feiring B, et al. Changes in carrier status of Neisseria meningitidis in teenagers during a group B outer membrane vaccination trial in Norway. In: Conde-Glez CJ, Morse S, and Rice P, et al. editors. Pathobiology and Immunobiology of Neisseriaceae. Cuernavaca, Morelos. Mexico: Instituto Nacional de Salud Publica; 1994. p. 895\u2013901."},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00751"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.033"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0869-7"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901229"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1244"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020407"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.12.034"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001896"},{"key":"e_1_3_5_76_1","unstructured":"Pfizer announces start of four phase 3 clinical trials for investigational vaccines: Pfizer Inc; 2020 [Cited 2021 October Feb]. Available from: https:\/\/investors.pfizer.com\/investor-news\/press-release-details\/2020\/Pfizer-Announces-Start-of-Four-Phase-3-Clinical-Trials-for-Investigational-Vaccines\/default.aspx"},{"key":"e_1_3_5_77_1","unstructured":"Study to Assess Effectiveness of GlaxoSmithKline\u2019s (GSK\u2019s) Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults.: clinicalTrial.gov U.S. National Library of Medicine; 2021 [Cited 2021 September Feb]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT04502693"},{"key":"e_1_3_5_78_1","unstructured":"Men ABCWY Noninferiority Study in Healthy Participants \u226510 to <26 years of age: clinicaltrials.gov U.S. National Library of Medicine.; 2021 [Cited 2021 October Feb]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04440163"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.10.024"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09946-1"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis892"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.016253"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.08.026"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.5.2692-2697.2000"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2014.55"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12451"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.055"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191261"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00188-17"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900236"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix162"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.14826.1"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2008.04.002"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.1996.tb02641.x"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.3109\/1040841X.2015.1022507"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2006.00052.x"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6503-6510.2004"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.129.6.1327"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01521-14"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1086\/424464"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.040"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix446"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3598-3"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix091"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.02.008"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820000734"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1551672"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1206.051297"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2015.12.011"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30842-2"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819001134"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05080-w"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024343"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.7.1111"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268816002119"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60842-4"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037358"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1733"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1186\/ISRCTN75858406"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027233"},{"key":"e_1_3_5_121_1","unstructured":"Marshall HS McMillan M and Koehler AP et al. Reduction in carriage of Neisseria meningitidis group W following implementation of meningococcal B and meningococcal ACWY vaccines in South Australian adolescents 38th Annual Meeting of the European Society for Paediatric Infectious Diseases (ESPID); 26-29 October 20202020."},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.08.007"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.03.001"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2022.2003708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:37:29Z","timestamp":1772761049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2022.2003708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/14760584.2022.2003708"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2022.2003708","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-05-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}